MEDICINES CO's ticker is MDCO and the CUSIP is 584688105. A total of 204 filers reported holding MEDICINES CO in Q4 2016. The put-call ratio across all filers is 2.04 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $61,658,000 | -3.9% | 1,816,674 | +6.8% | 0.01% | -10.0% |
Q3 2016 | $64,186,000 | +13.5% | 1,700,734 | +1.1% | 0.01% | +11.1% |
Q2 2016 | $56,553,000 | +4.9% | 1,681,626 | -0.9% | 0.01% | 0.0% |
Q1 2016 | $53,893,000 | -13.4% | 1,696,339 | +1.7% | 0.01% | -10.0% |
Q4 2015 | $62,262,000 | +1.5% | 1,667,435 | +3.2% | 0.01% | -9.1% |
Q3 2015 | $61,350,000 | +26.9% | 1,616,180 | -4.4% | 0.01% | +37.5% |
Q2 2015 | $48,343,000 | -0.6% | 1,689,707 | -2.7% | 0.01% | 0.0% |
Q1 2015 | $48,639,000 | -4.2% | 1,735,853 | -5.4% | 0.01% | 0.0% |
Q4 2014 | $50,770,000 | +18.3% | 1,834,849 | -4.6% | 0.01% | +14.3% |
Q3 2014 | $42,909,000 | -17.3% | 1,922,455 | +7.7% | 0.01% | -22.2% |
Q2 2014 | $51,892,000 | +2.3% | 1,785,689 | +0.0% | 0.01% | 0.0% |
Q1 2014 | $50,729,000 | -24.6% | 1,784,992 | +2.4% | 0.01% | -25.0% |
Q4 2013 | $67,308,000 | +15.2% | 1,742,817 | -0.0% | 0.01% | +9.1% |
Q3 2013 | $58,435,000 | -0.5% | 1,743,300 | -8.7% | 0.01% | -8.3% |
Q2 2013 | $58,731,000 | – | 1,909,315 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 4,202,000 | $153,246,000 | 19.10% |
Antipodean Advisors LLC | 257,000 | $9,373,000 | 11.40% |
Aviva Holdings Ltd. | 982,831 | $35,844,000 | 7.50% |
BRIDGER MANAGEMENT, LLC | 2,314,014 | $84,392,000 | 6.62% |
Slate Path Capital LP | 3,545,000 | $129,286,000 | 5.80% |
CVI Holdings, LLC | 338,850 | $12,357,000 | 4.78% |
DLD Asset Management, LP | 2,917,800 | $106,412,000 | 4.43% |
Camber Capital Management LP | 1,700,000 | $61,999,000 | 2.89% |
Maven Securities LTD | 109,386 | $3,994,000 | 2.66% |
Parian Global Management LP | 110,100 | $4,015,000 | 2.60% |